M. Bergaglio

501 citations
18 papers · 399 · h-index 12

Impact in

    • Cancer Treatment and Pharmacology
    • HER2/EGFR in Cancer Research
    • Cancer survivorship and care
    • Myasthenia Gravis and Thymoma

Papers in

M. Bergaglio

17 papers receiving 378 citations

Peers

M. Bergaglio
Comparison fields: 5 of 50
  • Oncology 173
  • Neurology 76
  • Endocrinology, Diabetes and Metabolism 75
  • Cancer Research 49
  • Pulmonary and Respiratory Medicine 71
Replace Mustafa Yaylacı with:
Mustafa Yaylacı Türkiye
Başak Oyan Türkiye
A. Oltra Spain
G. Mortimer Ireland
E. W. M. McDermott Ireland
N. Panza Italy
Judi Manola United States
Takehisa Hashimoto Japan
Ga Sze Hong Singapore
Mariam Jafri United Kingdom
M. Bergaglio relative to Mustafa Yaylacı Türkiye Mustafa Yaylacı's profile →
Citations per field
00.5×3.2×
Mustafa Yaylacı · 1×
Citations per year

Countries citing papers authored by M. Bergaglio

Since Specialization
Citations

This map shows the geographic impact of M. Bergaglio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Bergaglio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Bergaglio more than expected).

Fields of papers citing papers by M. Bergaglio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Bergaglio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Bergaglio. The network helps show where M. Bergaglio may publish in the future.

Co-authors

The 25 scholars most cited alongside M. Bergaglio, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with M. Bergaglio Line = papers co-authored together M. Bergaglio links everyone, so they are left out of the graph.

All Works

18 of 18 papers shown
#Work
1 200274
2 199961
3 200946
4 200238
5 201428
6 200124
7 202021
8 200121
9 200819
10 200218
11 200113
12
Effect of chemotherapy on somatostatin receptor detection with octreotide scintigraphy in hormone-refractory prostate cancer patients.
200611
13
Capecitabine in association with epirubicin and docetaxel as first line chemotherapy in advanced breast cancer A dose-finding study
20008
14
[Use of erythropoietin in oncology].
19988
15
Maintenance therapy with gefitinib after first-line chemotherapy in patients affected by advanced non-small cell lung cancer.
20083
16 20113
17
Toremifene as a substitute for adjuvant tamoxifen in breast cancer patients.
20012
18 19961

About M. Bergaglio

M. Bergaglio is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Neurology, Endocrinology, Diabetes and Metabolism and Cancer Research, having authored 18 papers that have together received 399 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (6 papers), Sarcoma Diagnosis and Treatment (2 papers), Advanced Breast Cancer Therapies (2 papers), Breast Cancer Treatment Studies (2 papers), Myasthenia Gravis and Thymoma (2 papers), Soft tissue tumors and treatment (1 paper), Childhood Cancer Survivors' Quality of Life (1 paper) and Cancer-related cognitive impairment studies (1 paper). The work is most often cited by research in Oncology (173 citations), Neurology (76 citations), Endocrinology, Diabetes and Metabolism (75 citations), Cancer Research (49 citations) and Pulmonary and Respiratory Medicine (71 citations). M. Bergaglio has collaborated with scholars based in Italy, United Kingdom and Switzerland. Frequent co-authors include M. Venturini, Lucia Del Mastro, R. Rosso, Massimo Costantini, Gianfilippo Bertelli, P. Pronzato, Ornella Garrone, Catia Angiolini, Nicoletta Biglia and Manlio Mencoboni. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, European Journal of Cancer, Breast Cancer Research and Treatment and Future Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact